Product name:Mitomycin
CAS:50-07-7
Molecular Formula:C15H18N4O5
Molecular Weight:334.33g/mol
Description:It is given intravenously to treat upper gastro-intestinal (e.g. esophageal carcinoma), anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours.It causes delayed bone marrow toxicity and therefore it is usually administered at 6-weekly intervals.Prolonged use may result in permanent bone-marrow damage.It may also cause lung fibrosis and renal damage.